Literature DB >> 33990525

First Report of SARS-CoV-2 Detection in Cerebrospinal Fluid in a Child With Guillain-Barré Syndrome.

Naiana Mota Araújo1, Lis Campos Ferreira2,3,4, Débora Paraíso Dantas3, Denison Santos Silva3, Cliomar Alves Dos Santos5, Rosana Cipolotti4, Paulo Ricardo Martins-Filho4,6.   

Abstract

Underlying mechanisms on the association between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and neurologic complications are still poorly understood. Cases of Guillain-Barré Syndrome (GBS) have been linked to the SARS-CoV-2 infection as the result of dysregulated immune response with damage in neuronal tissues. In the current report, we present the first pediatric case of GBS with detection of SARS-CoV-2 in the cerebrospinal fluid (CFS). This unique case of COVID-19-associated GBS with detection of SARS-CoV-2 RNA in the CSF indicates direct viral involvement inducing peripheral nerve inflammation.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33990525     DOI: 10.1097/INF.0000000000003146

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  11 in total

1.  COVID-19 and MOG-IgG-associated acquired demyelinating polyneuropathy compatible with chronic inflammatory demyelinating polyneuropathy in a previously healthy girl.

Authors:  Asra Akbar; Gregory M Blume; Sean Creeden; Sharjeel Ahmad
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-06-17

2.  Guillain-Barré Syndrome in a Child With Multisystem Inflammatory Syndrome Related to COVID-19.

Authors:  Maaloul Ines; Jallouli Leila; Gargouri Rania; Chabchoub Imen; Abid Leila; Aloulou Hajer; Kamoun Thouraya
Journal:  Pediatr Infect Dis J       Date:  2022-07-13       Impact factor: 3.806

Review 3.  Spectrum of neuroimaging mimics in children with COVID-19 infection.

Authors:  Alex Mun-Ching Wong; Cheng Hong Toh
Journal:  Biomed J       Date:  2021-11-15       Impact factor: 7.892

4.  Presence of Severe Acute Respiratory Syndrome Coronavirus 2 in the Cerebrospinal Fluid of Guillain-Barré Syndrome Patients Requires Validation.

Authors:  Josef Finsterer; Fulvio A Scorza
Journal:  Pediatr Infect Dis J       Date:  2021-12-01       Impact factor: 3.806

5.  Presence of SARS-CoV-2 in the CSF of Guillain-Barré Syndrome Patients Requires Validation.

Authors:  Paulo Ricardo Martins-Filho; Naiana Mota Araújo; Débora Paraíso Dantas; Denison Santos Silva; Cliomar Alves Dos Santos; Rosana Cipolotti; Lis Campos Ferreira
Journal:  Pediatr Infect Dis J       Date:  2021-12-01       Impact factor: 3.806

6.  Guillain-Barré syndrome is immunogenic in SARS-CoV-2 infected.

Authors:  Josef Finsterer; Talal Almas
Journal:  J Med Virol       Date:  2021-09-08       Impact factor: 2.327

7.  Possible association between Guillain-Barré syndrome and SARS-CoV-2 infection in children: A case report and literature review.

Authors:  Ilaria Mussinatto; Chiara Benevenuta; Anna Caci; Mario M Calvo; Maria Impastato; Massimo Barra; Egidio Genovese; Fabio Timeus
Journal:  Exp Ther Med       Date:  2022-05-23       Impact factor: 2.751

8.  Guillain-Barre syndrome 15 days after COVID-19 despite SARS-CoV-2 vaccination.

Authors:  Josef Finsterer
Journal:  IDCases       Date:  2021-07-12

9.  Relationship Between Acute Phase Reactants and Disability in Guillian-Barré Syndrome During the COVID-19 Pandemic.

Authors:  Recep Yevgi
Journal:  Arch Med Res       Date:  2021-10-18       Impact factor: 2.235

10.  Neurological complications of COVID-19 in pediatric patients require comprehensive evaluation.

Authors:  Josef Finsterer
Journal:  J Neurovirol       Date:  2022-03-11       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.